These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 14678636)

  • 21. Secondary prophylaxis for Leishmania infection in an HIV-positive patient.
    Orlando G; Del Sorbo F; Corbellino M; Schiavini M; Cargnel A
    AIDS; 1998 Oct; 12(15):2086-7. PubMed ID: 9814886
    [No Abstract]   [Full Text] [Related]  

  • 22. HIV--Leishmania infantum co-infection: humoral and cellular immune responses to the parasite after chemotherapy.
    Moreno J; Cañavate C; Chamizo C; Laguna F; Alvar J
    Trans R Soc Trop Med Hyg; 2000; 94(3):328-32. PubMed ID: 10975014
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased Leishmania replication in HIV-1-infected macrophages is mediated by tat protein through cyclooxygenase-2 expression and prostaglandin E2 synthesis.
    Barreto-de-Souza V; Pacheco GJ; Silva AR; Castro-Faria-Neto HC; Bozza PT; Saraiva EM; Bou-Habib DC
    J Infect Dis; 2006 Sep; 194(6):846-54. PubMed ID: 16941353
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Can type-1 responses against intracellular pathogens be T helper 2 cytokine dependent?
    Alexander J; McFarlane E
    Microbes Infect; 2008 Jul; 10(9):953-9. PubMed ID: 18762265
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Visceral leishmaniasis in those infected with HIV: clinical aspects and other opportunistic infections.
    Russo R; Laguna F; López-Vélez R; Medrano FJ; Rosenthal E; Cacopardo B; Nigro L
    Ann Trop Med Parasitol; 2003 Oct; 97 Suppl 1():99-105. PubMed ID: 14678637
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recombinant Leishmania tarentolae expressing the A2 virulence gene as a novel candidate vaccine against visceral leishmaniasis.
    Mizbani A; Taheri T; Zahedifard F; Taslimi Y; Azizi H; Azadmanesh K; Papadopoulou B; Rafati S
    Vaccine; 2009 Dec; 28(1):53-62. PubMed ID: 19818721
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum chemokine profiles in visceral leishmaniasis, HIV and HIV/ visceral leishmaniasis co-infected Ethiopian patients.
    Sisay Z; Berhe N; Petros B; Tegbaru B; Messele T; Hailu A; Wolday D
    Ethiop Med J; 2011 Jul; 49(3):179-86. PubMed ID: 21991751
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enzymatic polymorphism during Leishmania/HIV co-infection: a study of 381 Leishmania strains received between 1986 and 2000 at the international cryobank in Montpellier, France.
    Pratlong F; Dereure J; Deniau M; Marty P; Faraut-Gambarelli F; Dedet JP
    Ann Trop Med Parasitol; 2003 Oct; 97 Suppl 1():47-56. PubMed ID: 14678632
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Unusual manifestations of tegumentary leishmaniasis in AIDS patients from the New World.
    Lindoso JA; Barbosa RN; Posada-Vergara MP; Duarte MI; Oyafuso LK; Amato VS; Goto H
    Br J Dermatol; 2009 Feb; 160(2):311-8. PubMed ID: 19187345
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Leishmania infantum enhances human immunodeficiency virus type-1 replication in primary human macrophages through a complex cytokine network.
    Zhao C; Papadopoulou B; Tremblay MJ
    Clin Immunol; 2004 Oct; 113(1):81-8. PubMed ID: 15380533
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Leishmaniasis as an emerging infection.
    Choi CM; Lerner EA
    J Investig Dermatol Symp Proc; 2001 Dec; 6(3):175-82. PubMed ID: 11924824
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Complete protection against experimental visceral leishmaniasis with complete soluble antigen from attenuated Leishmania donovani promastigotes involves Th1-immunity and down-regulation of IL-10.
    Bhaumik SK; Naskar K; De T
    Eur J Immunol; 2009 Aug; 39(8):2146-60. PubMed ID: 19593771
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of Leishmania donovani-infected hamsters with miltefosine: analysis of cytokine mRNA expression by real-time PCR, lymphoproliferation, nitrite production and antibody responses.
    Gupta R; Kushawaha PK; Samant M; Jaiswal AK; Baharia RK; Dube A
    J Antimicrob Chemother; 2012 Feb; 67(2):440-3. PubMed ID: 22121191
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cellular and humoral responses induced by Leishmania histone H2B and its divergent and conserved parts in cutaneous and visceral leishmaniasis patients, respectively.
    Meddeb-Garnaoui A; Toumi A; Ghelis H; Mahjoub M; Louzir H; Chenik M
    Vaccine; 2010 Feb; 28(7):1881-6. PubMed ID: 20005858
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elongation factor-2, a Th1 stimulatory protein of Leishmania donovani, generates strong IFN-γ and IL-12 response in cured Leishmania-infected patients/hamsters and protects hamsters against Leishmania challenge.
    Kushawaha PK; Gupta R; Sundar S; Sahasrabuddhe AA; Dube A
    J Immunol; 2011 Dec; 187(12):6417-27. PubMed ID: 22079980
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Leishmania donovani secretory serine protease alters macrophage inflammatory response via COX-2 mediated PGE-2 production.
    Das P; De T; Chakraborti T
    Indian J Biochem Biophys; 2014 Dec; 51(6):542-51. PubMed ID: 25823228
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Flow cytometric determination of cellular sources and frequencies of key cytokine-producing lymphocytes directed against recombinant LACK and soluble Leishmania antigen in human cutaneous leishmaniasis.
    Bottrel RL; Dutra WO; Martins FA; Gontijo B; Carvalho E; Barral-Netto M; Barral A; Almeida RP; Mayrink W; Locksley R; Gollob KJ
    Infect Immun; 2001 May; 69(5):3232-9. PubMed ID: 11292745
    [TBL] [Abstract][Full Text] [Related]  

  • 38. B7-2 blockade enhances T cell responses to Leishmania donovani.
    Murphy ML; Engwerda CR; Gorak PM; Kaye PM
    J Immunol; 1997 Nov; 159(9):4460-6. PubMed ID: 9379045
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High frequency of asymptomatic Leishmania spp. infection among HIV-infected patients living in endemic areas for visceral leishmaniasis in Brazil.
    Orsini M; Canela JR; Disch J; Maciel F; Greco D; Toledo A; Rabello A
    Trans R Soc Trop Med Hyg; 2012 May; 106(5):283-8. PubMed ID: 22348817
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The identification and variability of the parasites causing leishmaniasis in HIV-positive patients in Italy.
    Gramiccia M
    Ann Trop Med Parasitol; 2003 Oct; 97 Suppl 1():65-73. PubMed ID: 14678634
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.